Ackman, Icahn Respond To Berkshire Criticism Of Activism

May 5 2014 | 2:20pm ET

Berkshire Hathaway’s second-in-command thinks shareholder activism is bad for America. Two of the strategy’s most prominent representatives agree—to a point.

Carl Icahn and Pershing Square Capital Management’s William Ackman, until a rapprochement last month bitter enemies, said they agreed with Charles Munger’s criticism of “short-term” activism. But they made clear that they don’t consider themselves short-termers.

“I 100% agree with them,” Ackman said. The Pershing Square chief, who attended Berkshire’s annual meeting this weekend in Omaha, Neb., said that pushing for short-term gains without long-term benefits to a company is “bad for markets, and it’s bad for shareholders.”

By contrast, Pershing Square typically holds its investments for “four, five, six years or more,” he said.

For his part, Ichan said he understands “and somewhat agree with their criticisms that some activists are going for a short-term pop.” But, he warned, “that doesn’t mean you throw the baby out with the bath water. One of the most important things we need in this country is to keep companies accountable.”

Munger told the assembled Berkshire shareholders of activism, “I don’t think it’s good for America.” And he and Berkshire chief Warren Buffett warned that the menace is here to stay.

“They are certainly attracting more and more money,” Buffett said. “I don’t think it will go away, and I think it scares the hell out of a lot of managers.”


In Depth

Bob Doll's Ten Market Predictions For 2016

Jan 7 2016 | 9:37pm ET

Well-known market strategist Robert Doll has published his annual list of ten predictions...

Lifestyle

Citadel's Ken Griffin Donates $40M To New York's Museum of Modern Art

Dec 22 2015 | 9:23pm ET

Citadel founder Ken Griffin has donated $40 million to New York’s Museum of Modern...

Guest Contributor

Hedge Fund Marketing - Making the Most of Your Salesperson

Jan 20 2016 | 8:11pm ET

In this contributed article, Bruce Frumerman of Frumerman & Nemeth takes a close...